Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program

Fernandez Fernandez, Angeles; Romero Picos , Esperanza

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/4310

ISSN: 0006-4971

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2014

Journal title

Blood

Type of content

Publicación de congreso